Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer

Chimeric antigen receptor (CAR)-modified natural killer (NK) cell therapy represents a kind of promising anti-cancer treatment because CAR renders NK cells activation and recognition specificity toward tumor cells. An immune checkpoint molecule, B7-H3, plays an inhibitory role in modulation of NK ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuo, Cao, Bihui, Zhou, Guangyu, Zhu, Lipeng, Wang, Lu, Zhang, Li, Kwok, Hang Fai, Zhang, Zhenfeng, Zhao, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406658/
https://www.ncbi.nlm.nih.gov/pubmed/32848731
http://dx.doi.org/10.3389/fphar.2020.01089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406658/
https://www.ncbi.nlm.nih.gov/pubmed/32848731
http://dx.doi.org/10.3389/fphar.2020.01089

Ejemplares similares